首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p
Authors:Yi Liu  Gongming Zhang  Hao Chen  Hua Wang
Institution:1.Department of Pathology, The First People’s Hospital of Lianyungang, No.6 Zhenhua Dong Rd, Lianyungang 222002, Jiangsu Province, China;2.Department of Medicine, The First People’s Hospital of Lianyungang, No.6 Zhenhua Dong Rd, Lianyungang 222002, Jiangsu Province, China
Abstract:Lung adenocarcinoma (LUAD), a common type of lung cancer, has become a popularly aggressive cancer. Long noncoding RNAs (lncRNAs) play a critical role in the pathogenesis of human cancers, while the function of double homeobox A pseudogene 8 (DUXAP8) in LUAD remains to be fully inquired. Therefore, our study was conducted to elucidate the DUXAP8 expression in LUAD and its mechanism on the biological features of LUAD cells. Loss-of-function experiments were performed to assess the function of DUXAP8 proliferation and apoptosis of H1975 and A549 cells. Functionally, silencing DUXAP8 inhibited proliferation and induced apoptosis of LUAD cells. Mechanistically, further correlation assay indicated a negative association between miR-26b-5p and DUXAP8 expression. Subsequently, we testified that DUXAP8 exerted its role in the progression and development of LUAD through targeting miR-26b-5p. In summary, our results elucidated that that DUXAP8 promoted tumor progression in LUAD by targeting miR-26b-5p, which provide a novel therapeutic target for diagnosis and therapy of LUAD.
Keywords:Apoptosis  DUXAP8  Lung adenocarcinoma  MiR-26b-5p  Proliferation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号